2.79
price down icon4.45%   -0.13
after-market After Hours: 2.80 0.010 +0.36%
loading
Sonoma Pharmaceuticals Inc stock is traded at $2.79, with a volume of 126.71K. It is down -4.45% in the last 24 hours and down -6.69% over the past month. Sonoma Pharmaceuticals Inc is a specialty pharmaceutical company operating in the United States. It is engaged in identifying, developing, and commercializing differentiated therapies for patients living with chronic skin conditions. The company focuses on the development and commercialization of therapeutic solutions in medical dermatology to treat skin conditions, such as acne, atopic dermatitis, and scarring. The key products of the company are Celacyn, Ceramax Skin Barrier Cream, Mondoxyne, Alevicyn, SebuDerm, Microcyn, and Microcyn which are available for various skin treatments such as scars, itchy skin, minor skin irritations, rashes, and others. The company derives revenue from the sale of products in the United States, Latin America, Europe, Asia, and other countries.
See More
Previous Close:
$2.92
Open:
$2.85
24h Volume:
126.71K
Relative Volume:
0.38
Market Cap:
$3.84M
Revenue:
$12.31M
Net Income/Loss:
$-5.08M
P/E Ratio:
-1.8355
EPS:
-1.52
Net Cash Flow:
$-5.20M
1W Performance:
-1.76%
1M Performance:
-6.69%
6M Performance:
-29.30%
1Y Performance:
-15.45%
1-Day Range:
Value
$2.73
$2.92
1-Week Range:
Value
$2.70
$3.138
52-Week Range:
Value
$2.52
$9.374

Sonoma Pharmaceuticals Inc Stock (SNOA) Company Profile

Name
Name
Sonoma Pharmaceuticals Inc
Name
Phone
800-759-9305
Name
Address
5445 CONESTOGA COURT, SUITE 150, BOULDER, CA
Name
Employee
171
Name
Twitter
Name
Next Earnings Date
2024-11-11
Name
Latest SEC Filings
Name
SNOA's Discussions on Twitter

Compare SNOA with other stocks

Stocks Price Market Cap Revenue Net Income Cash Flow EPS
Drug Manufacturers - Specialty & Generic icon
SNOA
Sonoma Pharmaceuticals Inc
2.79 3.84M 12.31M -5.08M -5.20M -1.52
Drug Manufacturers - Specialty & Generic icon
ZTS
Zoetis Inc
176.74 80.59B 9.15B 2.43B 2.31B 4.92
Drug Manufacturers - Specialty & Generic icon
HLN
Haleon Plc Adr
9.72 44.17B 14.26B 1.55B 0 0.3327
Drug Manufacturers - Specialty & Generic icon
TAK
Takeda Pharmaceutical Co Adr
13.57 42.61B 30.27B 1.93B 3.45B 0.444
Drug Manufacturers - Specialty & Generic icon
TEVA
Teva Pharmaceutical Industries Ltd Adr
16.57 18.77B 16.77B -959.00M 1.37B -2.00
Drug Manufacturers - Specialty & Generic icon
VTRS
Viatris Inc
13.22 15.73B 15.05B -883.30M 1.89B 1.53

Sonoma Pharmaceuticals Inc Stock (SNOA) Latest News

pulisher
Nov 27, 2024

Despite Fast-paced Momentum, Sonoma Pharmaceuticals (SNOA) Is Still a Bargain Stock - Yahoo Finance

Nov 27, 2024
pulisher
Nov 26, 2024

Sonoma Pharmaceuticals (STU:O8Z) Growth Rank : 2 (As of Nov. 26, 2024) - GuruFocus.com

Nov 26, 2024
pulisher
Nov 23, 2024

Eye Care Product Lines - Trend Hunter

Nov 23, 2024
pulisher
Nov 22, 2024

Alkermes (ALKS) Stock Surges Over 5% Amid Strong Financial Perfo - GuruFocus.com

Nov 22, 2024
pulisher
Nov 22, 2024

Sonoma Pharmaceuticals, Inc. Receives New FDA 510(K) Clearance for Microcyn(R)-Based Wound Care Hydrogel - Marketscreener.com

Nov 22, 2024
pulisher
Nov 22, 2024

Scar Treatment Market Detailed In New Research Report 2024 | - openPR

Nov 22, 2024
pulisher
Nov 22, 2024

Sonoma Pharmaceuticals ends agreement with EMC Pharma - Investing.com

Nov 22, 2024
pulisher
Nov 21, 2024

Merck (MRK) Stock Surges Amid Industry Layoff Trends - GuruFocus.com

Nov 21, 2024
pulisher
Nov 21, 2024

Sonoma Pharmaceuticals ends agreement with EMC Pharma By Investing.com - Investing.com Australia

Nov 21, 2024
pulisher
Nov 21, 2024

Sonoma Pharmaceuticals Announces Relaunch of Prescription Dermatology and Eye Care Product Lines in - PharmiWeb.com

Nov 21, 2024
pulisher
Nov 21, 2024

Amarin (AMRN) Stock Surges Amid Mixed Industry Performance - GuruFocus.com

Nov 21, 2024
pulisher
Nov 21, 2024

Sonoma Pharmaceuticals Announces Relaunch of Prescription Dermatology and Eye Care Product Lines in the United States - AccessWire

Nov 21, 2024
pulisher
Nov 21, 2024

Sonoma Pharmaceuticals, Inc. Announces Relaunch of Prescription Dermatology and Eye Care Product Lines in the United States - Marketscreener.com

Nov 21, 2024
pulisher
Nov 20, 2024

Sonoma Pharmaceuticals, Inc. Reports Earnings Results for the Second Quarter and Six Months Ended September 30, 2024 - Marketscreener.com

Nov 20, 2024
pulisher
Nov 20, 2024

U.S. shares lower at close of trade; Dow Jones Industrial Average down 0.86% - MSN

Nov 20, 2024
pulisher
Nov 14, 2024

Animal Wound Care Market to Exhibit a Remarkable CAGR of 7.9% - openPR

Nov 14, 2024
pulisher
Nov 12, 2024

AMGN Stock Drops 5% Amid Industry Decline and Earnings Report - GuruFocus.com

Nov 12, 2024
pulisher
Nov 12, 2024

Siga Technologies (SIGA) Sees Significant Stock Decline Amidst P - GuruFocus.com

Nov 12, 2024
pulisher
Nov 12, 2024

Sonoma Pharmaceuticals gains FDA clearance for hydrogel By Investing.com - Investing.com Australia

Nov 12, 2024
pulisher
Nov 12, 2024

Sonoma Pharmaceuticals (NASDAQ:SNOA) Share Price Passes Above Two Hundred Day Moving Average – Here’s Why - Defense World

Nov 12, 2024
pulisher
Nov 11, 2024

Sonoma Pharmaceuticals gains FDA clearance for hydrogel - Investing.com India

Nov 11, 2024
pulisher
Nov 11, 2024

Sonoma Pharmaceuticals Receives New FDA 510(k) Clearance for Microcyn(R)-based Wound Care Hydrogel - AccessWire

Nov 11, 2024
pulisher
Nov 11, 2024

Pre-market Movers: REVB, CDIO, SMLR, DWTX... - RTTNews

Nov 11, 2024
pulisher
Nov 09, 2024

Sonoma Pharmaceuticals Second Quarter 2025 Earnings: EPS Beats Expectations, Revenues Lag - Yahoo Finance

Nov 09, 2024
pulisher
Nov 07, 2024

Sonoma Pharmaceuticals Inc. (SNOA) Quarterly 10-Q Report - Quartz

Nov 07, 2024
pulisher
Nov 07, 2024

Sonoma Pharmaceuticals Inc (SNOA) Quarterly 10-Q Report - Quartzy

Nov 07, 2024
pulisher
Nov 07, 2024

Sonoma Pharmaceuticals Reports Second Fiscal Quarter 2025 Financial Results - AccessWire

Nov 07, 2024
pulisher
Nov 04, 2024

Certain Options of Sonoma Pharmaceuticals, Inc. are subject to a Lock-Up Agreement Ending on 29-JAN-2020. - Marketscreener.com

Nov 04, 2024
pulisher
Nov 04, 2024

Certain Restricted Stock Units of Sonoma Pharmaceuticals, Inc. are subject to a Lock-Up Agreement Ending on 29-JAN-2020. - Marketscreener.com

Nov 04, 2024
pulisher
Nov 04, 2024

Certain Warrants of Sonoma Pharmaceuticals, Inc. are subject to a Lock-Up Agreement Ending on 29-JAN-2020. - Marketscreener.com

Nov 04, 2024
pulisher
Nov 04, 2024

Certain Preferred stock of Sonoma Pharmaceuticals, Inc. are subject to a Lock-Up Agreement Ending on 29-JAN-2020. - Marketscreener.com

Nov 04, 2024
pulisher
Oct 31, 2024

Sonoma Pharmaceuticals to Exhibit at MEDICA 2024 in Düsseldorf - AccessWire

Oct 31, 2024
pulisher
Oct 31, 2024

Sonoma Pharmaceuticals, Inc. to Exhibit At MEDICA 2024 in Dusseldorf - Marketscreener.com

Oct 31, 2024
pulisher
Oct 24, 2024

Sonoma Pharmaceuticals (SNOA) Surges Amid Positive Analyst Ratin - GuruFocus.com

Oct 24, 2024
pulisher
Oct 24, 2024

Unveiling the Future: Animal Wound Care Market to USD 1.24 BILLION IN 2023, Forecast by 2030, Featuring a C... - WhaTech

Oct 24, 2024
pulisher
Oct 22, 2024

Sonoma Pharmaceuticals Announces Expanded Partnership with Global Healthcare Distributor for Distribution of Wound Care Products in Canada - AccessWire

Oct 22, 2024
pulisher
Oct 21, 2024

Sonoma Pharmaceuticals to Present at Danisavage Financial Strategies, and LD Micro Main Event XVII Investor Conferences - AccessWire

Oct 21, 2024
pulisher
Oct 21, 2024

Scar Treatment Market to See Booming Growth 2024-2031 | Bausch - openPR

Oct 21, 2024
pulisher
Oct 18, 2024

Keloid Treatment Market Latest Report 2023-2031 - InsightAce Analytic

Oct 18, 2024
pulisher
Oct 17, 2024

Sonoma Pharmaceuticals, Inc. (NASDAQ:SNOA) Stock's 43% Dive Might Signal An Opportunity But It Requires Some Scrutiny - Simply Wall St

Oct 17, 2024
pulisher
Oct 16, 2024

Recent Developments in the Eye Skin Care Market - openPR

Oct 16, 2024
pulisher
Oct 15, 2024

Keloid Treatment Market: Insights Predicting a $4.72 Billion Valuation by 2031 - WhaTech

Oct 15, 2024
pulisher
Oct 14, 2024

Hypertrophic Scar Treatment Market Growth, Trends, and Industry Share Analysis (2024-2032) - News in Assen

Oct 14, 2024
pulisher
Oct 11, 2024

Sonoma Pharmaceuticals (SNOA) Shares Surge Amid Positive Market Activity - GuruFocus.com

Oct 11, 2024
pulisher
Oct 11, 2024

Sonoma Pharmaceuticals (NASDAQ:SNOA) Stock Price Crosses Above Two Hundred Day Moving AverageTime to Sell? - MarketBeat

Oct 11, 2024
pulisher
Oct 10, 2024

Williams-Sonoma, Inc. (WSM) is Attracting Investor Attention: Here is What You Should Know - Yahoo Finance

Oct 10, 2024

Sonoma Pharmaceuticals Inc Stock (SNOA) Financials Data

Revenue

loading

Net Income

loading

Cash Flow

loading

EPS

loading
$90.27
price up icon 0.83%
$13.13
price up icon 0.00%
$86.59
price up icon 0.19%
$61.00
price up icon 0.41%
$126.59
price down icon 1.03%
$13.22
price up icon 1.07%
Cap:     |  Volume (24h):